Stereoselectivity in drug development. A clinical perspective?

Veterinary Journal

Volumn 165, Issue 1, 2003, Pages 3-4

  Van Miert, A S J P A ^a  

^a Department of Veterinary Pharmacol ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BARBITURIC ACID DERIVATIVE; CARMOTEROL; CLENBUTEROL; DEXAMISOLE; DEXFENFLURAMINE; DRUG; FENFLURAMINE; IBUPROFEN; KETOPROFEN; LEVALBUTEROL; LEVAMISOLE; TETRAMISOLE; THALIDOMIDE; XENOBIOTIC AGENT; VETERINARY DRUG;

DRUG ACTIVITY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; EDITORIAL; ENANTIOSELECTIVITY; HUMAN; NONHUMAN; RACEMIC MIXTURE; SIDE EFFECT; STEREOCHEMISTRY; ANIMAL; ANIMAL DISEASE; CHEMISTRY; DRUG DESIGN; NOTE; STEREOISOMERISM;

ANIMAL DISEASES; ANIMALS; DRUG DESIGN; STEREOISOMERISM; VETERINARY DRUGS;

EID: 0037981408     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-0233(02)00188-0     Document Type: Editorial

References (13)

1. Ariens E.J. Van Rensen J.J.S. Welling W. Stereoselectivity of pesticides 1988 Elsevier Scientific Publications Amsterdam
2. Cayen M.N. Perspectives of industry on the development of stereoisomeric drugs Naunyn-Schmiedeberg's Archives of Pharmacology 358 Suppl. 2 1998 R761
3. Delatour P. Benoit E. Soraci A. Ruckebusch Memorial lecture: Drug chirality, its significance in veterinary pharmacology and therapeutics Proceedings of the Sixth International Congress of the European Association of Veterinary Pharmacology and Therapeutics, Edinburgh 7-11 August, 1994 1994 6-9 Blackwell Scientific Publication
4. Eichelbaum M. The enantiomer versus racemate debate: a clinical perspective Naunyn-Schmiedeberg's Archives of Pharmacology 358 Suppl. 2 1998 R761
5. Handley D. The asthma-like pharmacology and toxicology of (S)-isomers of beta-agonists Journal of Allergy and Clinical Immunology 104 1999 69-72
6. Izeboud C.A. Vermeulen R.M. Zwart A. Voss H.S. Van Miert A.S.J.P.A. Witkamp R.F. Stereoselectivity at the beta-adrenoreceptor on macrophages is a major determinant of the anti-inflammatory effects of beta2-agonists Naunyn-Schmiedeberg's Archives of Pharmacology 362 2000 184-189
7. Jamali F. Mehvar R. Pasutto M. Enantioselective aspects of drug action and disposition: therapeutic pitfalls Journal of Pharmaceutical Sciences 78 1989 695-715
8. Lees P. Taylor P.M. Landoni P.M. Arifah A.K. Waters C. Ketoprofen in the cat: pharmacodynamic and chiral pharmacokinetics The Veterinary Journal 165 2003 19-33
9. Schuttler J. S-ketamine: development of a stereochemical pure drug from racemate. Experience of an investigator Naunyn-Schmiedeberg's Archives of Pharmacology 358 Suppl. 2 1998 R761
10. Somogyi A. Stereoselectivity in drug disposition Naunyn-Schmiedeberg's Archives of Pharmacology 358 Suppl. 2 1998 R760
11. Wainer I.W. Drug stereochemistry 1993 Marcel Dekker Inc New York
12. Walle T. Webb J.G. Bagwell E.E. Walle U.K. Daniell H.B. Gaffney T.E. Stereoselective delivery and actions of beta receptor antagonists Biochemical Pharmacology 37 1988 115-124
13. Wieland K. Zuurmond H.M. Krasel C. Yzerman A.P. Lohse M.J. Involvement of asn-293 in stereospecific agonist recognition and in activation of beta2-adrenergic receptor Proceedings of the National Academy of Sciences USA 93 1996 9276-9281